Imatinib for Multiple Sclerosis (MS) Relapses

Clinical trial NCT03674099 · UNKNOWN

Trial details

NCT number: NCT03674099
Sponsor: Tomas Olsson
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2018-10-01
Primary completion: 2022-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.